[Use of the peristaltic moderator Reasec in the therapy of diarrheas following x-ray and radioisotope therapy].
D000008:Abdominal Neoplasms / Q000532:radiotherapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D003036:Cobalt Isotopes; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D008297:Male; D008614:Meperidine / Q000627:therapeutic use; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000532:radiotherapy; D011867:Radioisotope Teletherapy; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage
D003036:Cobalt Isotopes; D005765:Gastrointestinal Agents; D008614:Meperidine
Anwendung des Peristaltikomoderators Reasec zur Therapie von Diarrhöen nach Röntgenbestrahlung oder Behandlung mit radioaktiven Isotopen.